Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Southern Transforaminal Lumbar Interbody Fusion (TLIF)

K-Number: K221182 · 2022-12-08

Decision Date2022-12-08
Product CodeMAX
Advisory CommitteeOR
DecisionSubstantially Equivalent

Device Summary

Southern Transforaminal Lumbar Interbody Fusion (TLIF) is a medical device manufactured by Southern Medical (Pty) , Ltd.. It received FDA 510(k) clearance on 2022-12-08 under approval number K221182. The device is classified under product code MAX. It was reviewed by the OR advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Southern Transforaminal Lumbar Interbody Fusion (TLIF)?

Southern Transforaminal Lumbar Interbody Fusion (TLIF) is a medical device that received FDA 510(k) clearance on 2022-12-08. It is manufactured by Southern Medical (Pty) , Ltd.. The 510(k) number is K221182.

When was Southern Transforaminal Lumbar Interbody Fusion (TLIF) approved by the FDA?

Southern Transforaminal Lumbar Interbody Fusion (TLIF) received FDA 510(k) clearance on 2022-12-08, under approval number K221182.

What company makes Southern Transforaminal Lumbar Interbody Fusion (TLIF)?

Southern Transforaminal Lumbar Interbody Fusion (TLIF) is manufactured by Southern Medical (Pty) , Ltd..

What is the FDA product code for Southern Transforaminal Lumbar Interbody Fusion (TLIF)?

The FDA product code for Southern Transforaminal Lumbar Interbody Fusion (TLIF) is MAX.

Related Clinical Trials

Related PubMed Literature

Other Devices by Southern Medical (Pty) , Ltd.

Related Devices (Code: MAX)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.